In fact, most thyroid cancer cells overexpressed IR, which can amplify the biological effects of IGF-1 through forming hybrid IR/IGF-1R receptors that will bind IGF-1 with high affinity. The gene discussed is IGF1; the disease is thyroid gland carcinoma.